The study indicated that, in tumor samples from patients with recurrence, the NNMT expression was elevated while the DNMT1 expression was reduced, resulting in tumor cell resistance to oxidative phosphorylation inhibitors, thus rendering these treatments ineffective and promoting tumor relapse. The gene discussed is DNMT1; the disease is neoplasm.